People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Biotechnology, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ivenix, Inc. | — | Biotechnology | Series B | $82.9M | $396.9M | 2017 |
| AltheaDx, Inc. | — | Biotechnology | Series B | $51.8M | $137.3M | 2015 |
| Zhejiang Expressway Co Ltd | — | Other | Series B | $17.4M | $123.6M | 2023 |
| Cytovia Holdings, Inc. | — | Biotechnology | Series A | $11.5M | $12.7M | 2022 |
| Voyce, Inc. | — | Other Technology | Pre-Seed | $1.1M | $12.7M | 2018 |
| WEYI, Inc. | — | Other | Pre-Seed | $1.0M | $23.1M | 2018 |
| East West Wine Co | — | Other | Pre-Seed | $125K | $2.9M | 2011 |
Wei Li at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wei Li on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Wu | 2 | 4 |
| Ketan Patel | 1 | 10 |
| John Clarke | 1 | 8 |
| Magda Marquet | 1 | 6 |
| Wayne B. Weisman | 1 | 5 |
| Brandon Hull | 1 | 5 |
| John K. Clarke | 1 | 5 |
| David Nikodem | 1 | 4 |
| Michael Friedman | 1 | 4 |
| Jason Liu | 1 | 4 |
| J. Matthew Mackowski | 1 | 4 |
| Andrew Jackson | 1 | 4 |
| MICHAEL NOONAN | 1 | 3 |
| Thomas Robinson | 1 | 3 |
| Bin Chen | 1 | 3 |
| Gregory Fiore | 1 | 3 |
| Jeffrey G. Black | 1 | 3 |
| Yuh-geng Tsay | 1 | 2 |
| Darrell Crate | 1 | 2 |
| Francois Ferre | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.